Biofrontera AG Sponsored ADR EV/Sales

EV/Sales of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.

Highlights and Quick Summary

Current EV/Sales of Biofrontera AG Sponsored ADR is 2.38 (as of December 31, 2021)
  • EV/Sales for the quarter ending June 30, 2022 was 1.99 (a 5.99% increase compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -53.23%
  • Annual EV/Sales for 2021 was 2.38 (a -59.22% decrease from previous year)
  • Annual EV/Sales for 2021 was 5.82 (a 9.27% increase from previous year)
  • Annual EV/Sales for 2020 was 5.33 (a -25.56% decrease from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of Biofrontera AG Sponsored ADR

Most recent EV/Salesof BFAGY including historical data for past 10 years.

Interactive Chart of EV/Sales of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – – 1.99 1.88 –
2021 2.38 4.26 5.18 3.69 2.38
2020 5.33 5.3 4.46 4.95 5.33
2019 – 7.16 12.23 14.36 7.16
2018 – – – 6.53 5.51
2017 – – 0.0 0.0 0.0
2016 0.0 – – – 0.0

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com